OMICS Trademark

Trademark Overview

On Tuesday, December 19, 2017, a trademark application was filed for OMICS with the United States Patent and Trademark Office. The USPTO has given the OMICS trademark a serial number of 87727253. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 27, 2021. This trademark is owned by NantHealth, Inc.. The OMICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services for both medical and non-medical purposes based on genomic and proteomic analyses and providing custom consulting services related thereto; development of new technology for others in the field of genomics and proteomics
omics

General Information

Serial Number87727253
Word MarkOMICS
Filing DateTuesday, December 19, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements

Goods and ServicesScientific research services for both medical and non-medical purposes based on genomic and proteomic analyses and providing custom consulting services related thereto; development of new technology for others in the field of genomics and proteomics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 5, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNantHealth, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCulver City, CA 90232
Party NameNantHealth, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCulvery City, CA 90232

Trademark Events

Event DateEvent Description
Thursday, January 28, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 27, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 16, 2020NON-FINAL ACTION E-MAILED
Thursday, July 16, 2020NON-FINAL ACTION WRITTEN
Monday, July 13, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 10, 2020NOTICE OF ALLOWANCE CANCELLED
Saturday, January 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 23, 2020EXTENSION 1 GRANTED
Thursday, January 23, 2020EXTENSION 1 FILED
Thursday, January 23, 2020TEAS EXTENSION RECEIVED
Sunday, September 15, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, September 15, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 22, 2019ASSIGNED TO LIE
Monday, April 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 3, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 3, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, October 3, 2018SUSPENSION LETTER WRITTEN
Saturday, September 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2018NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2018NON-FINAL ACTION WRITTEN
Wednesday, March 28, 2018ASSIGNED TO EXAMINER
Friday, January 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 22, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

omics medical services development related thereto technology field proteomics genomics consulting